Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.66
-0.13-0.77%
Last update: Oct 16, 4:44 PM
$16.66
-0.13-0.77%
ArriVent BioPharma Inc (AVBP) Stock Price, Quote, News & History
AVBPNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.
Other companies in ArriVent BioPharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
ArriVent BioPharma has a consensus price target of $33.00.
The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $16.66 last updated October 16, 2026 at 4:44 PM EDT.
There are no upcoming dividends for ArriVent BioPharma.
ArriVent BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for ArriVent BioPharma.
ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
